National Cancer Medicines Advisory Group (NCMAG)

We deliver advice that supports timely and fair access to medicines uses that are safe and effective.  These can be either

  •  off-label medicines uses for on- or off-patent medicines
  • on-label medicines uses for off-patent medicines only

These medicines uses are outside the remit of Scottish Medicines Consortium (SMC). We do not consider medicines without a UK marketing authorisation.

NHS Scotland Specialist cancer teams propose medicines uses to us to consider.

Published advice

Medicine uses we have advised on

Medicine uses under review

Medicine uses scheduled to be reviewed

NCMAG reports

Reports published by NCMAG

How to submit a medicine for review

Clinicians can ask us to review certain uses of cancer medicines

Programme information

Information on the purpose of NCMAG